Rating History for Inhibikase Therapeutics Inc (IKT) by Chardan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/13/2026 | Andreas Argyrides | New Coverage | Neutral (N/A) |
1.50 (N/A) |
1.97 (1.65) |
-16.24% | Details |
